denufosol tetrasodium (INS37217) Inhalation Solution

DRUG4 trials

Sponsors

Merck Sharp & Dohme LLC

Conditions

Cystic Fibrosis

Phase 1

A Study in Adult and Pediatric Patients With Cystic Fibrosis

CompletedNCT00034515

Merck Sharp & Dohme LLCCystic Fibrosis

Start: 2001-06-30End: 2002-08-31Updated: 2015-02-16

Phase 2

Study of Denufosol Inhalation Solution in Patients With Mild to Moderate Cystic Fibrosis Lung Disease

TerminatedNCT00425165

Merck Sharp & Dohme LLCCystic Fibrosis

Start: 2007-08-31End: 2008-05-31Updated: 2015-04-03

Phase 3

Study of Denufosol Inhalation Solution in Patients With Mild Cystic Fibrosis Lung Disease

CompletedNCT00357279

Merck Sharp & Dohme LLCCystic Fibrosis

Start: 2006-07-31End: 2008-09-30Updated: 2015-11-04

Study of Denufosol Tetrasodium Inhalation Solution in Patients With Cystic Fibrosis (CF) Lung Disease

CompletedNCT00625612

Merck Sharp & Dohme LLCCystic Fibrosis

Start: 2008-02-29End: 2010-10-31Updated: 2015-11-02

Related Papers

Long term effects of denufosol tetrasodium in patients with cystic fibrosis.

2012-06-0870 citations

Denufosol tetrasodium in patients with cystic fibrosis and normal to mildly impaired lung function.

2010-12-1761 citations